olorigliflozin   Click here for help

GtoPdb Ligand ID: 14656

Synonyms: DJT1116PG | Dongze'an® (China) | rongliflozin
Approved drug
olorigliflozin is an approved drug
Compound class: Synthetic organic
Comment: Olorigliflozin (DJT1116PG) is an orally bioavailable Sodium/glucose cotransporter 2 (SGLT2; SLC5A2) inhibitor.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 4
Rotatable bonds 6
Topological polar surface area 108.61
Molecular weight 450.91
XLogP 0.76
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCOC1=CC=C(C=C1)CC2=CC(=CC=C2Cl)[C@]34[C@@H]([C@H]([C@@H]([C@@](CO3)([C@@H](C)O)O4)O)O)O
Isomeric SMILES CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)[C@@H](C)O)O)O)O)Cl
InChI InChI=1S/C23H27ClO7/c1-3-29-17-7-4-14(5-8-17)10-15-11-16(6-9-18(15)24)23-21(28)19(26)20(27)22(31-23,12-30-23)13(2)25/h4-9,11,13,19-21,25-28H,3,10,12H2,1-2H3/t13-,19+,20+,21-,22-,23+/m1/s1
InChI Key KODGTDKHPNYCCJ-YWRILDCISA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Zhang H, Liu J, Zhu X, Li X, Chen H, Wu M, Li C, Ding Y. (2020)
A Phase I Study on the Pharmacokinetics and Pharmacodynamics of DJT1116PG, a Novel Selective Inhibitor of Sodium-glucose Cotransporter Type 2, in Healthy Individuals at Steady State.
Clin Ther, 42 (5): 892-905.e3. [PMID:32265061]
2. Zhang H, Zhu X, Li X, Chen H, Wu M, Li C, Liu J, Liu C, Zhang Y, Ding Y. (2020)
Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium-glucose co-transporter-2, in people with type 2 diabetes mellitus.
Diabetes Obes Metab, 22 (2): 191-202. [PMID:31588657]